tiprankstipranks
Trending News
More News >
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market

Cabaletta Bio (CABA) Financial Statements

Compare
1,103 Followers

Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently $141.21M. The company's EPS TTM is $; its P/E ratio is ―; Cabaletta Bio is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -1.43M$ -3.68M$ -733.00K$ -354.00K
Operating Income$ -125.14M$ -74.66M$ -54.14M$ -46.31M$ -33.83M
EBITDA$ -125.14M$ -73.23M$ -52.96M$ -45.58M$ -33.48M
Net Income$ -115.86M$ -67.67M$ -52.98M$ -46.29M$ -33.34M
Balance Sheet
Cash & Short-Term Investments$ 163.96M$ 241.25M$ 106.55M$ 122.22M$ 108.66M
Total Assets$ 185.05M$ 253.65M$ 116.97M$ 126.34M$ 114.72M
Total Debt$ 15.60M$ 5.02M$ 5.14M$ 0.00$ 0.00
Net Debt$ -148.36M$ -188.22M$ -76.47M$ -122.22M$ -101.43M
Total Liabilities$ 32.71M$ 17.45M$ 12.45M$ 8.38M$ 5.18M
Stockholders' Equity$ 152.34M$ 236.20M$ 104.52M$ 117.96M$ 109.54M
Cash Flow
Free Cash Flow$ -90.43M$ -54.24M$ -48.83M$ -35.27M$ -27.41M
Operating Cash Flow$ -88.22M$ -53.55M$ -46.38M$ -34.11M$ -26.77M
Investing Cash Flow$ 47.29M$ -22.45M$ -27.22M$ 6.00M$ -7.98M
Financing Cash Flow$ 11.68M$ 187.63M$ 32.98M$ 48.90M$ -24.00K
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis